SERPINF1 and cancer: Meta-analysis with the pooled data revealed that cancers with low PEDF expression have an increased odds to be high grade than those with high PEDF expression (OR = 1.6, 95% CI: 1.2–2.13, fixed-effect model, I2 = 33%, P = 0.17) (Fig. 5a).